Dow Up0.11% Nasdaq Up0.50%

Meridian Bioscience, Inc. (VIVO)

-NasdaqGS
19.58 Down 0.05(0.25%) 3:59PM EDT
|After Hours : 19.57 Down 0.01 (0.05%) 4:23PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Sep 30, 2012Sep 30, 2011
Total Revenue 188,686   172,712   158,836  
Cost of Revenue67,642  63,664  60,425  
Gross Profit 121,044   109,048   98,411  
Operating Expenses
Research Development10,787  10,275  9,822  
Selling General and Administrative52,943  49,477  48,556  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 57,314   49,296   40,033  
Income from Continuing Operations
Total Other Income/Expenses Net48  420  467  
Earnings Before Interest And Taxes57,362  49,716  40,500  
Interest Expense -   -   -  
Income Before Tax57,362  49,716  40,500  
Income Tax Expense19,330  16,345  13,669  
Minority Interest -   -   -  
Net Income From Continuing Ops38,032  33,371  26,831  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 38,032   33,371   26,831  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 38,032   33,371   26,831  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.